Th9 lymphocytes: A recent history from IL-9 to its potential role in rheumatic diseases

Autoimmunity Reviews

Volumn 15, Issue 7, 2016, Pages 649-655

  Rojas Zuleta, Wilmer Gerardo ^a   Vásquez, Gloria ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Interleukin 9; Rheumatoid arthritis; Systemic lupus erythematous; Systemic sclerosis; Th9 lymphocytes

Indexed keywords

B CELL ACTIVATING TRANSCRIPTION FACTOR; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 9; STAT5 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CYTOKINE RELEASE; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TH9 CELL; ANIMAL; HELPER CELL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; HUMANS; INTERLEUKIN-9; LUPUS ERYTHEMATOSUS, SYSTEMIC; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84960984465     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.02.020     Document Type: Review

References (73)

1. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136(7):2348-2357.
2. Schmitt E., Van Brandwijk R., Fischer H.G., Rude E. Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors. Eur J Immunol 1990, 20(8):1709-1715.
3. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010, 28:445-489.
4. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260(5107):547-549.
5. Le Gros G., Ben-Sasson S.Z., Seder R., Finkelman F.D., Paul W.E. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990, 172(3):921-929.
6. + T cells. Science 2010, 327(5969):1098-1102.
7. Locksley R.M. Nine lives: plasticity among T helper cell subsets. J Exp Med 2009, 206(8):1643-1646.
8. Jabeen R., Kaplan M.H. The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol 2012, 24(3):303-307.
9. Van Snick J., Goethals A., Renauld J.C., Van Roost E., Uyttenhove C., Rubira M.R., et al. Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med 1989, 169(1):363-368.
10. + T cells but is not a general T cell growth factor. Eur J Immunol 1989, 19(11):2167-2170.
11. Stassen M., Schmitt E., Bopp T. From interleukin-9 to T helper 9 cells. Ann N Y Acad Sci 2012, 1247:56-68.
12. + T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 1994, 153(9):3989-3996.
13. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008, 9(12):1341-1346.
14. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100(6):655-669.
15. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89(4):587-596.
16. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299(5609):1057-1061.
17. + T helper cells. Cell 2006, 126(6):1121-1133.
18. + Foxp3(-) effector T cells. Nat Immunol 2008, 9(12):1347-1355.
19. Staudt V., Bothur E., Klein M., Lingnau K., Reuter S., Grebe N., et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010, 33(2):192-202.
20. Chang H.C., Sehra S., Goswami R., Yao W., Yu Q., Stritesky G.L., et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010, 11(6):527-534.
21. Wong M.T., Ye J.J., Alonso M.N., Landrigan A., Cheung R.K., Engleman E., et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol 2010, 88(6):624-631.
22. Jones C.P., Gregory L.G., Causton B., Campbell G.A., Lloyd C.M. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol 2012, 129(4). 1000-10.e3.
23. Yao W., Tepper R.S., Kaplan M.H. Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol 2011, 128. United States. p. 1357-60.e5.
24. Tan C., Aziz M.K., Lovaas J.D., Vistica B.P., Shi G., Wawrousek E.F., et al. Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J Immunol 2010, 185(11):6795-6801.
25. Janeway C.A., Bottomly K. Signals and signs for lymphocyte responses. Cell 1994, 76(2):275-285.
26. Xiao X., Balasubramanian S., Liu W., Chu X., Wang H., Taparowsky E.J., et al. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol 2012, 13(10):981-990.
27. Mochizuki K., He S., Zhang Y. Notch and inflammatory T cell response: new developments and challenges. Immunotherapy 2011, 3(11):1353-1366.
28. Elyaman W., Bassil R., Bradshaw E.M., Orent W., Lahoud Y., Zhu B., et al. Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 2012, 36(4):623-634.
29. Angkasekwinai P., Chang S.H., Thapa M., Watarai H., Dong C. Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 2010, 11(3):250-256.
30. Mikami N., Miyagi Y., Sueda K., Takatsuji M., Fukada S., Yamamoto H., et al. Calcitonin gene-related peptide and cyclic adenosine 5'-monophosphate/protein kinase A pathway promote IL-9 production in Th9 differentiation process. J Immunol 2013, 190(8):4046-4055.
31. Yao W., Zhang Y., Jabeen R., Nguyen E.T., Wilkes D.S., Tepper R.S., et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013, 38(2):360-372.
32. Kaplan M.H. Th9 cells: differentiation and disease. Immunol Rev 2013, 252(1):104-115.
33. Liao W., Spolski R., Li P., Du N., West E.E., Ren M., et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc Natl Acad Sci U S A 2014, 111(9):3508-3513.
34. Goswami R., Jabeen R., Yagi R., Pham D., Zhu J., Goenka S., et al. STAT6-dependent regulation of Th9 development. J Immunol 2012, 188(3):968-975.
35. Chang H.C., Zhang S., Thieu V.T., Slee R.B., Bruns H.A., Laribee R.N., et al. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 2005, 22(6):693-703.
36. Goswami R., Kaplan M.H. Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells. J Immunol 2012, 189(6):3026-3033.
37. Jabeen R., Goswami R., Awe O., Kulkarni A., Nguyen E.T., Attenasio A., et al. Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest 2013, 123(11):4641-4653.
38. Jash A., Sahoo A., Kim G.C., Chae C.S., Hwang J.S., Kim J.E., et al. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-kappaB (NF-kappaB)-mediated interleukin-9 (IL-9) transactivation. J Biol Chem 2012, 287(19):15445-15457.
39. Noelle R.J., Nowak E.C. Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 2010, 10(10):683-687.
40. Renauld J.C., Goethals A., Houssiau F., Van Roost E., Van Snick J. Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40. Cytokine 1990, 2(1):9-12.
41. Nicolaides N.C., Holroyd K.J., Ewart S.L., Eleff S.M., Kiser M.B., Dragwa C.R., et al. Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A 1997, 94(24):13175-13180.
42. Perumal N.B., Kaplan M.H. Regulating IL-9 transcription in T helper cells. Trends Immunol 2011, 32(4):146-150.
43. Demoulin J.B., Renauld J.C. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther 1998, 4(4):243-256.
44. Knoops L., Renauld J.C. IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 2004, 22(4):207-215.
45. Houssiau F.A., Renauld J.C., Stevens M., Lehmann F., Lethe B., Coulie P.G., et al. Human T cell lines and clones respond to IL-9. J Immunol 1993, 150(7):2634-2640.
46. Hultner L., Druez C., Moeller J., Uyttenhove C., Schmitt E., Rude E., et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol 1990, 20(6):1413-1416.
47. Yang Y.C., Ricciardi S., Ciarletta A., Calvetti J., Kelleher K., Clark S.C. Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. Blood 1989, 74(6):1880-1884.
48. Zhao P., Xiao X., Ghobrial R.M., Li X.C. IL-9 and Th9 cells: progress and challenges. Int Immunol 2013, 25(10):547-551.
49. Temann U.A., Laouar Y., Eynon E.E., Homer R., Flavell R.A. IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int Immunol 2007, 19(1):1-10.
50. Dugas B., Renauld J.C., Pene J., Bonnefoy J.Y., Peti-Frere C., Braquet P., et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993, 23(7):1687-1692.
51. Xing J., Wu Y., Ni B. Th9: a new player in asthma pathogenesis?. J Asthma 2011, 48(2):115-125.
52. Purwar R., Schlapbach C., Xiao S., Kang H.S., Elyaman W., Jiang X., et al. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 2012, 18(8):1248-1253.
53. Faulkner H., Humphreys N., Renauld J.C., Van Snick J., Grencis R. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur J Immunol 1997, 27(10):2536-2540.
54. Townsend J.M., Fallon G.P., Matthews J.D., Smith P., Jolin E.H., McKenzie N.A. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000, 13(4):573-583.
55. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442(7106):997-1002.
56. Pan H.F., Leng R.X., Li X.P., Zheng S.G., Ye D.Q. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases. Cytokine Growth Factor Rev 2013, 24(6):515-522.
57. Jilani A.A., Mackworth-Young C.G. The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol 2015, 2015:728610.
58. Hitchon C.A., Alex P., Erdile L.B., Frank M.B., Dozmorov I., Tang Y., et al. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 2004, 31(12):2336-2346.
59. Kokkonen H., Soderstrom I., Rocklov J., Hallmans G., Lejon K., Rantapaa D.S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010, 62(2):383-391.
60. Deane K.D., O'Donnell C.I., Hueber W., Majka D.S., Lazar A.A., Derber L.A., et al. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 2010, 62(11):3161-3172.
61. Khan I.H., Krishnan V.V., Ziman M., Janatpour K., Wun T., Luciw P.A., et al. A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin Cytom 2009, 76(3):159-168.
62. Brzustewicz E., Bryl E. The role of cytokines in the pathogenesis of rheumatoid arthritis - Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine 2015.
63. Hughes-Austin J.M., Deane K.D., Derber L.A., Kolfenbach J.R., Zerbe G.O., Sokolove J., et al. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 2013, 72(6):901-907.
64. Ciccia F., Guggino G., Rizzo A., Manzo A., Vitolo B., La Manna M.P., et al. Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2015.
65. Dantas A.T., Marques C.D., da Rocha Junior L.F., Cavalcanti M.B., Goncalves S.M., Cardoso P.R., et al. Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?. Dis Markers 2015, 2015:519638.
66. Leng R.X., Pan H.F., Ye D.Q., Xu Y. Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus. Am J Clin Exp Immunol 2012, 1(1):28-32.
67. Yang J., Li Q., Yang X., Li M. Interleukin-9 Is associated with elevated anti-double-stranded DNA antibodies in lupus-prone mice. Mol Med 2015, 21:364-370.
68. + T cells in patients with systemic lupus erythematosus. Mol Med Rep 2013, 7(3):1031-1037.
69. Nowak E.C., Noelle R.J. Interleukin-9 as a T helper type 17 cytokine. Immunology 2010, 131(2):169-173.
70. Fleming J.N., Schwartz S.M. The pathology of scleroderma vascular disease. Rheum Dis Clin North Am 2008, 34(1):41-55. vi.
71. Baraut J., Michel L., Verrecchia F., Farge D. Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 2010, 10(2):65-73.
72. Scala E., Pallotta S., Frezzolini A., Abeni D., Barbieri C., Sampogna F., et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004, 138(3):540-546.
73. Yanaba K., Yoshizaki A., Asano Y., Kadono T., Sato S. Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol 2011, 38(10):2193-2197.